Generic placeholder image

Current Nutrition & Food Science

Editor-in-Chief

ISSN (Print): 1573-4013
ISSN (Online): 2212-3881

Research Article

Immigrant Usage Patterns of Natural Health Products: Role in Pharmacoeconomics

Author(s): Dalya Abdulla*

Volume 16, Issue 1, 2020

Page: [45 - 55] Pages: 11

DOI: 10.2174/1573401315666181206120420

Price: $65

Abstract

Background: Understanding patterns and drivers for natural health product (NHP) usage among immigrants is essential in the provision of appropriate health care; many studies have elucidated NHP utilization among immigrants; however, few have considered impacts of concurrent NHP and prescription medication usage.

Objective: The study aims to determine new immigrant NHP usage patterns (including concurrent usage with prescription medications) and to discern economic impacts driving concurrent usage.

Methods: A survey questionnaire was administered to local new immigrants during English Language Training classes.

Results: Most participants understood the NHP definition and would take an NHP for the same disease or condition they would normally take a prescription medication for. Many participants agreed that NHPs are not safe however were unable to provide robust examples of unsafe NHP usage. With regard to purchases of medicines for short and long term illnesses, a high percentage of participants would purchase the prescription medication for a short term illness over the NHP; however this percentage decreases in the event of a long term illness, with more participants relying on NHPs to remedy their long term illness symptoms.

Conclusion: Pharmacoeconomics tends to be a major driver for immigrant utilization of NHPs, and is a stronger influencer of use compared to ethnicity or parenteral usage of such products. This pharmacoeconomic correlation in the preference to use NHPs over prescription medications tends to be more observable for chronic and long term conditions (compared to short term illnesses).

Keywords: Acute illness, chronic illness, ethnicity, natural health products, pharmacoeconomics, prescription medications.

Graphical Abstract
[1]
Venkataramanan R, Komoroski B, Strom S. In vitro and in vivo assessment of herb drug interactions. Life Sci 2006; 78(18): 2105-15.
[http://dx.doi.org/10.1016/j.lfs.2005.12.021] [PMID: 16427092]
[2]
Chavez ML, Jordan MA, Chavez PI. Evidence-based drug--herbal interactions. Life Sci 2006; 78(18): 2146-57.
[http://dx.doi.org/10.1016/j.lfs.2005.12.009] [PMID: 16427091]
[3]
Sewitch MJ, Yaffe M, Maisonneuve J, Prchal J, Ciampi A. Use of complementary and alternative medicine by cancer patients at a Montreal hospital. Integr Cancer Ther 2011; 10(4): 305-11.
[http://dx.doi.org/10.1177/1534735410395136] [PMID: 21382961]
[4]
Zulkipli AF, Islam T, Mohd Taib NA, et al. MyBCC Study Group. Use of complementary and alternative medicine among newly diagnosed breast cancer patients in Malaysia: an early report from the MyBCC study. Integr Cancer Ther 2018; 17(2): 312-21.
[http://dx.doi.org/10.1177/1534735417745248] [PMID: 29218996]
[5]
Nguyen LT, Kaptchuk TJ, Davis RB, et al. The Use of traditional vietnamese medicine among Vietnamese immigrants attending an urban community health center in the United States. J Altern Complement Med 2016; 22(2): 145-53.
[http://dx.doi.org/10.1089/acm.2014.0209] [PMID: 26630121]
[6]
Zörgő S, Purebl G, Zana Á. A qualitative study of culturally embedded factors in complementary and alternative medicine use. BMC Complement Altern Med 2018; 18(1): 25.
[http://dx.doi.org/10.1186/s12906-018-2093-0] [PMID: 29357855]
[7]
NCCIH. Complementary, Alternative, or Integrative Health What’s In a Name? 2016.Available at: https: //nccih.nih.gov/health/ integrative-health#cvsa
[8]
Anon. . Natural Health Products 2014. Available at: . http: //www.hc-sc.gc.ca/dhp-mps/prodnatur/index-eng.php
[9]
Kelly JP, Kaufman DW, Kelley K, Rosenberg L, Mitchell AA. Use of herbal/natural supplements according to racial/ethnic group. J Altern Complement Med 2006; 12(6): 555-61.
[http://dx.doi.org/10.1089/acm.2006.12.555] [PMID: 16884347]
[10]
Howell L, Kochhar K, Saywell R Jr, et al. Use of herbal remedies by Hispanic patients: do they inform their physician? J Am Board Fam Med 2006; 19(6): 566-78.
[http://dx.doi.org/10.3122/jabfm.19.6.566] [PMID: 17090790]
[11]
Singh SR, Levine MA. Natural health product use in Canada: analysis of the National Population Health Survey. Can J Clin Pharmacol 2006; 13(2): e240-50.
[PMID: 16921199]
[12]
Levine MA, Xu S, Gaebel K, et al. Self-reported use of natural health products: a cross-sectional telephone survey in older Ontarians. Am J Geriatr Pharmacother 2009; 7(6): 383-92.
[http://dx.doi.org/10.1016/j.amjopharm.2009.12.003] [PMID: 20129259]
[13]
Pal D, Mitra AK. MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci 2006; 78(18): 2131-45.
[http://dx.doi.org/10.1016/j.lfs.2005.12.010] [PMID: 16442130]
[14]
Kennedy J. Herb and supplement use in the US adult population. Clin Ther 2005; 27(11): 1847-58.
[http://dx.doi.org/10.1016/j.clinthera.2005.11.004] [PMID: 16368456]
[15]
van der Watt ASJ, Nortje G, Kola L, et al. Collaboration between biomedical and complementary and alternative care providers: barriers and pathways. Qual Health Res 2017; 27(14): 2177-88.
[http://dx.doi.org/10.1177/1049732317729342] [PMID: 28901831]
[16]
Johnson SB, Park HS, Gross CP, Yu JB. Complementary medicine, refusal of conventional cancer therapy, and survival among patients with curable cancers. JAMA Oncol 2018; 4(10): 1375-81.
[http://dx.doi.org/10.1001/jamaoncol.2018.2487] [PMID: 30027204]
[17]
Dean JA, Wilson K. “My health has improved because I always have everything I need here”: a qualitative exploration of health improvement and decline among immigrants. Soc Sci Med 2010; 70(8): 1219-28.
[http://dx.doi.org/10.1016/j.socscimed.2010.01.009] [PMID: 20167409]
[18]
Newbold KB. Health care use and the Canadian immigrant population. Int J Health Serv 2009; 39(3): 545-65.
[http://dx.doi.org/10.2190/HS.39.3.g] [PMID: 19771955]
[19]
Newbold B. The short-term health of Canada’s new immigrant arrivals: evidence from LSIC. Ethn Health 2009; 14(3): 315-36.
[http://dx.doi.org/10.1080/13557850802609956] [PMID: 19263262]
[21]
Naja F, Alameddine M, Abboud M, Bustami D, Al Halaby R. Complementary and alternative medicine use among pediatric patients with leukemia: the case of Lebanon. Integr Cancer Ther 2011; 10(1): 38-46.
[http://dx.doi.org/10.1177/1534735410384591] [PMID: 21059622]
[22]
Sharpe PA, Blanck HM, Williams JE, Ainsworth BE, Conway JM. Use of complementary and alternative medicine for weight control in the United States. J Altern Complement Med 2007; 13(2): 217-22.
[http://dx.doi.org/10.1089/acm.2006.6129] [PMID: 17388764]
[23]
Mehta DH, Gardiner PM, Phillips RS, McCarthy EP. Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions. J Altern Complement Med 2008; 14(10): 1263-9.
[http://dx.doi.org/10.1089/acm.2008.0290] [PMID: 19032071]
[24]
Kav S, Pinar G, Gullu F, et al. Use of complementary and alternative medicine in patients with gynecologic cancer: is this usage more prevalent? J Altern Complement Med 2008; 14(4): 347-9.
[http://dx.doi.org/10.1089/acm.2008.0019] [PMID: 18435602]
[25]
Greenlee H, Kwan ML, Ergas IJ, et al. Complementary and alternative therapy use before and after breast cancer diagnosis: The Pathways Study. Breast Cancer Res Treat 2009; 117(3): 653-65.
[http://dx.doi.org/10.1007/s10549-009-0315-3] [PMID: 19184414]
[26]
Jones RA, Utz S, Wenzel J, et al. Use of complementary and alternative therapies by rural African Americans with type 2 diabetes. Altern Ther Health Med 2006; 12(5): 34-8.
[PMID: 17017753]
[27]
Najm W, Reinsch S, Hoehler F, Tobis J. Use of complementary and alternative medicine among the ethnic elderly. Altern Ther Health Med 2003; 9(3): 50-7.
[PMID: 12776475]
[28]
Kuo GM, Hawley ST, Weiss LT, Balkrishnan R, Volk RJ. Factors associated with herbal use among urban multiethnic primary care patients: a cross-sectional survey. England. BMC Complement Altern Med 2004; 18.
[29]
Graham RE, Gandhi TK, Borus J, et al. Risk of concurrent use of prescription drugs with herbal and dietary supplements in ambulatory care. In: Henriksen K, Battles JB, Keyes MA, Grady ML, EdsAdvances in patient safety: new directions and alternative approaches US: Technology and Medication Safety. Agency for Healthcare Research and Quality Rockville, MD. 2008; p. 4.
[30]
Kennedy J, Wang CC, Wu CH. Patient disclosure about herb and supplement use among adults in the US. Evid Based Complement Alternat Med 2008; 5(4): 451-6.
[http://dx.doi.org/10.1093/ecam/nem045]
[31]
Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med 2016; 176(4): 473-82.
[http://dx.doi.org/10.1001/jamainternmed.2015.8581] [PMID: 26998708]
[32]
Shelley BM, Sussman AL, Williams RL, Segal AR, Crabtree BF, Rios Net C. Rios Net Clinicians. ‘They don’t ask me so I don’t tell them’: patient-clinician communication about traditional, complementary, and alternative medicine. Ann Fam Med 2009; 7(2): 139-47.
[http://dx.doi.org/10.1370/afm.947] [PMID: 19273869]
[33]
Green RR, Santoro N, Allshouse AA, Neal-Perry G, Derby C. Prevalence of complementary and alternative medicine and herbal remedy use in Hispanic and non-Hispanic white women: results from the study of women’s health across the nation. J Altern Complement Med 2017; 23(10): 805-11.
[http://dx.doi.org/10.1089/acm.2017.0080] [PMID: 28915061]
[34]
Evans EA, Herman PM, Washington DL, et al. Gender differences in use of complementary and integrative health by U.S. military veterans with chronic musculoskeletal pain. Womens Health Issues 2018; 28(5): 379-86.
[http://dx.doi.org/10.1016/j.whi.2018.07.003] [PMID: 30174254]
[35]
Johnson PJ, Jou J, Rockwood TH, Upchurch DM. Perceived benefits of using complementary and alternative medicine by race/ ethnicity among midlife and older adults in the United States. J Aging Health 2019; 31(8): 1376-97.
[http://dx.doi.org/10.1177/0898264318780023] [PMID: 29900809]
[36]
Renton KW. Cytochrome P450 regulation and drug biotransformation during inflammation and infection. Curr Drug Metab 2004; 5(3): 235-43.
[http://dx.doi.org/10.2174/1389200043335559] [PMID: 15180493]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy